AITOPAI热报
ChinaLawProposedModel providersDeployersChina outbound

China to add AI, biopharma and solar tech to export control list

中国将AI、生物医药和太阳能技术纳入出口管制清单
商务部·Published 2026-10-16·Checked by 管理员 on 2026-10-17

China plans to add AI, biopharma and solar technologies to its export control list, meaning exports of these technologies will be restricted and require prior approval. The specific scope, approval process and effective date have not yet been announced.

Source ↗Remind meChina · All

What it means for you

  • Cross-border export or transfer of AI, biopharma or solar technology will require approval, so companies must plan licensing ahead
  • Companies in China transferring relevant technology to overseas subsidiaries or customers, including in ASEAN, must assess licence requirements
  • Scope and effective date are undetermined; track forthcoming list details closely

    • What to do

    ComplianceInventory existing cross-border exports and transfers of AI, biopharma and solar technology to build a licensing needs list
    LegalPause or reassess imminent outbound technology licensing and transfer deals pending detailed rules on approval pathways
    EveryoneMonitor MOFCOM announcements on the controlled items scope and effective date

    Key dates

    2026-10-16Published

    Source documents

    Source ↗

    Coverage

    Stories in the feed
    Editorial summary, not legal advice; dates and status follow the original document. · Report a correction